AIMZERI
Live / Applied — Non-final action mailed (as of 04 Feb 2026)
What this means for you
Not registered yet, but its 09 Oct 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99435352
- Mark type
- Stylized text
- Filed
- 09 Oct 2025
- Attorney of record
- Yana Gorbach
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, respiratory, and viral diseases and disorder; Pharmaceuticals, namely, anti-infectives; Medicated dermatological preparations and substances; Antifungal preparations; Smoking cessation preparations; Vaccines for human use; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, hormonal disorders, skin disorders, arthritis, cancer, cachexia, hypertension, migraine, pain, stroke, obesity and diabetes
Owner
- Pfizer Inc., New York, NY, US
Prosecution history
- 04 Feb 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 04 Feb 2026 — NON-FINAL ACTION E-MAILED
- 04 Feb 2026 — NON-FINAL ACTION WRITTEN
- 04 Feb 2026 — ASSIGNED TO EXAMINER
- 30 Jan 2026 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 30 Jan 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Jan 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 30 Jan 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 09 Oct 2025 — APPLICATION FILING RECEIPT MAILED
- 09 Oct 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 09 Oct 2025 — NEW APPLICATION ENTERED